Back to School: How biopharma can reboot drug development. Access exclusive analysis here
MTRA and Bayer's diagnostics division will develop MTRA's biochemical bone markers internationally. Bayer will market automated central laboratory
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury